Ultrasound Needle Guides Market Size, Share & Industry Analysis, By Type (Reusable and Disposable), By Application (Biopsy, Regional Anesthesia, Vascular Access, Nerve Block, Fluid Aspiration and Others), By End-user (Hospitals & ASCs, Clinics, Diagnostic Imaging Centers and Others), and Regional Forecast, 2026-2034

The global ultrasound needle guides market size was valued at USD 391.7 million in 2025. The market is projected to grow from USD 416.1 million in 2026 to USD 620.6 million by 2034, exhibiting a CAGR of 5.1% during the forecast period.

Ultrasound needle guides are accessories that are attached to an ultrasound probe, creating a fixed, predictable path for needles during image-guided procedures. These guides keep the needle aligned with ultrasound beam, which shortens procedure time, improves needle visualization and reduces complications. The market growth is influenced by an increasing shift toward minimally invasive procedures and ultrasound-guided procedures, such as biopsy procedures and fluid aspiration procedures.

Furthermore, the market is dominated by major players, including CIVCO Medical Solutions, GE Healthcare and FUJIFILM Sonosite, Inc. These companies are focusing on enhancing their portfolio and expanding geographical reach, which is expected to help in capturing a significant market portion.

MARKET DYNAMICS

MARKET DRIVERS

Rising Volume of Ultrasound-Guided Minimally Invasive Procedures to Drive Market Growth

Over the past few years, there has been a surge in replacement of landmark-based techniques with ultrasound guidance, from liver prostate biopsy to central line placement and regional anesthesia. Through this technology, even less experienced clinicians are able to perform procedures with accuracy and precision, which is additionally driving the adoption of these devices, thereby accelerating the global ultrasound needle guides market growth.

• For instance, according to data from the National Center for Biotechnology Information (NCBI) in October 2025, a study at University Hospital Würzburg, Germany, reported that out of 250 biopsies performed, 132 (52.8%) used CT guidance and 118 (47.2%) used ultrasound guidance.

MARKET RESTRAINTS

Price Sensitivity and Capital Budget Constraints in Certain Countries to Restrict Market Growth

Despite the higher significance of needle guides, they are often treated as low-margin accessories bundled with probes or sold through group purchasing contracts. Moreover, in middle-and low-income countries, hospitals and clinics are favoring cheaper and reusable guides, which is limiting the adoption of premium disposable guides. Such scenarios are anticipated to hinder the market expansion during the forecast period. Moreover, key players are broadly supplying similar disposable and reusable guides compatible with the same probes, increasing price competition and hindering product adoption in mature markets.

MARKET OPPORTUNITIES

AI, Sensor-Enabled Tracking, and Advanced Materials to Offer Lucrative Growth Opportunities

In recent years, deep learning-based needle tracking, such as DeepSight’s NeedleVue, which embeds sensors to verify real-time needle position, has shown promise for overcoming poor needle visibility in conventional 2D ultrasound. In response, companies are beginning to commercialize these systems in the market, offering lucrative opportunities for innovations.

• For instance, in September 2024, Rivanna Medical, Inc. secured US Patent #11,432,801 B2 for an advanced ultrasound-guided needle insertion system featuring a dual-array probe for enhanced visibility and precision in biopsies, ablations, and catheter placements.

Moreover, key players are also focusing on eco-friendly materials for disposable guides and investing in guides specifically optimized for emerging micro-ultrasound and handheld scanners.

ULTRASOUND NEEDLE GUIDES MARKET TRENDS

Shift Toward Disposable and Transperineal Solutions to Emerge as a Key Market Trend

Currently, there is a significant shift from reusable metal guides to sterile disposables, especially in oncology and IVF, to reduce cross-contamination and reprocessing time. Also, the shift or urology to transperineal prostate biopsy is attributed to guideline support and lower sepsis rates.

This, in turn, is influencing key players, including GEOTEK, CIVCO Medical Solutions, and others, to increase the development of specialized transperineal guides compatible with a wide range of probes.

MARKET CHALLENGES

Training Gaps and Workflow Integration to Challenge Market Growth

In several specialties, particularly regional anesthesia and emergency medicine, there remains a significant training gap in operating ultrasound-guided biopsy procedures. Additionally, there is a shortage of professionals in several countries, which is leading to delays in such procedures, limiting the utilization of ultrasound needle guides. Moreover, hospitals are also facing inventory and supply-chain complexity, managing their stocks for multiple probe-specific guides and disposable procedure kits. Such scenarios are anticipated to challenge the market expansion.

• For instance, according to the data from Health Carousel, LLC., in December 2025, health systems in the U.S. face a looming shortage of over 3.0 million healthcare professionals, prompting urgent efforts to address critical workforce shortages.

Download Free sample to learn more about this report.

Segmentation Analysis

By Type

Significant Advantages of Disposable Guides to Drive Segmental Growth

Based on the type segmentation, the market is classified as Reusable and Disposable.

To know how our report can help streamline your business, Speak to Analyst

The disposable segment accounted for the largest global ultrasound needle guides market share in 2025. Disposable guides offer significant benefits comparatively such as eliminating reprocessing steps, reducing cross-contamination risk, and simplifying logistics for interventional radiology suites and day-care centers. This is increasing the adoption of disposable needle guides, which is anticipated to drive the segment’s growth.

In addition, the reusable segment is projected to grow at a CAGR of 4.5% during the forecast period.

By Application

Increasing Number of Biopsy Procedures to Drive the Segment’s Growth

Based on application, the market is segmented into biopsy, regional anesthesia, vascular access, nerve block, fluid aspiration and others.

By application, the biopsy segment accounted for the largest share in 2025. The segment’s growth is attributed to increasing number of prostate biopsies worldwide and the shift from CT-guided to ultrasound-guided procedures, which is expected to fuel the adoption of ultrasound needle guides in the forthcoming years.  Furthermore, the segment is expected to hold a 31.6% share in 2026.

• For instance, according to data published by UCLA Health in December 2024, nearly 1 million prostate biopsies are performed annually in the U.S., and elevated PSA levels prompt these.

In addition, the vascular access segment is projected to grow at a CAGR of 5.4% during the forecast period.

By End-user

Surge in Ultrasound-guided Procedures Performed in Hospitals & ASCs Globally Drives the Segment Growth

Based on end-user, the market is segmented into hospitals & ASCs, clinics, diagnostic imaging centers, and others.

In 2025, the global market was dominated by hospitals & ASCs in terms of end-user. The growth is attributed to a higher volume of ultrasound-guided procedures performed in hospitals & ambulatory surgical centers due to accessibility to better care and partnership of reimbursement providers within these settings. Furthermore, the segment is set to hold 69.2% share in 2026.

In addition, the clinics segment is projected to grow at a CAGR of 5.1% during the forecast period.

Ultrasound Needle Guides Market Regional Outlook

By geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valuing at USD 121.0 million, and also maintained the leading share in 2025, with USD 128.4 million. The growth is attributed to the favorable reimbursement for ultrasound-guided interventions and the increasing number of hospitals & ASCs in the U.S., additionally contributing higher performance of these interventions. In 2026, the U.S. market is estimated to reach USD 126.9 million.

• For instance, according to the data from MedPAC, Medicare-certified ASCs increased by 2.5% to 6,308 facilities from 2022 to 2023.

Europe and Asia Pacific

Other regions, such as Europe and the Asia Pacific, are projected to expand at a notable rate in the forthcoming years. During the forecast period, the Europe region is projected to record a growth rate of 5.0%, the second-highest among all regions, and reach a valuation of USD 123.2 million by 2026. This growth is attributed to the large patient pool of prostate cancer in the region. Due to such factors, countries including U.K. are anticipated to record the valuation of USD 14.7 million, Germany to record USD 32.1 million, and France to record USD  19.3 million in 2026. After Europe, the market in Asia Pacific is estimated to reach USD 120.1 million in 2026  and secure the position of the third-largest region in the market. In the region, India and China are both estimated to reach USD 8.2 million and USD 42.7 million, respectively, in 2026. This growth is attributed to increasing healthcare infrastructure, including hospitals and diagnostic imaging centers in India and China, which is expected to favor the utilization of ultrasound needle guides in several interventions.

Latin America and Middle East & Africa

Over the forecast period, the Latin America and Middle East & Africa regions are expected to showcase moderate growth in the market. The Latin America market in 2026 is set to reach a valuation of USD 20.7 million. This growth is attributed to increasing awareness of ultrasound-guided procedures in Brazil, Chile, Mexico, and Portugal. In the Middle East & Africa, the GCC is set to reach a value of USD 11.3 million by 2026.

COMPETITIVE LANDSCAPE

Key Industry Players

Focus on Innovations and Product Diversification to Strengthen the Position of Key Players

In 2025, CIVCO Medical Solutions, GE Healthcare, and FUJIFILM Sonosite, Inc. accounted for the largest market share. The share is attributed to increasing innovations and product diversification efforts by these companies.

Other prominent companies, including GEOTEK, Sheathing Technologies, Inc., and others, are involved in the commercialization of products, partnering with healthcare facilities, and expanding geographic reach, which is anticipated to enhance their market share in the upcoming years. 

LIST OF KEY ULTRASOUND NEEDLE GUIDES MARKET COMPANIES PROFILED

• CIVCO Medical Solutions (U.S.)
• GE Healthcare (U.S.)
• FUJIFILM Sonosite, Inc. (U.S.)
• Sheathing Technologies, Inc. (U.S.)
• Aspen Surgical (U.S.)
• Argon Medical Devices (U.S.)
• GEOTEK (U.S.)
• Mermaid Medical (Denmark)

KEY INDUSTRY DEVELOPMENTS

• October 2025: Rivanna Medical, Inc. was awarded a USD 3.0 million Congressionally Directed Medical Research Program (CDMRP) grant to develop a military-optimized ultrasound guidance system for spinal interventions.
• September 2025: Rivanna Medical, Inc. received a USD 2.21 million Small Business Innovation Research (SBIR) Direct to Phase II (R44) grant from the National Cancer Institute (NCI) at the National Institutes of Health (NIH) to develop an ultrasound guidance system for pediatric lumbar punctures (LPs) using its Accuro 3S platform.
• November 2023: DeepSight Technology introduced NeedleVue, an ultrasound-guided needle technology using proprietary sensors to provide real-time verification of tool position and enhance safety.
• April 2023: BD launched the Prevue II System, an advanced ultrasound device with real-time needle depth markers and BD Cue Needle Tracking to enhance first-stick success in IV insertions for difficult vascular access.
• March 2021: ECIO LEAPMED launched the X-Needle Guide Disposable Guide V3.0, a new version of its ultrasound-guided disposable needle guide, emphasizing high precision and ease of use in interventional procedures.

REPORT COVERAGE

The global ultrasound needle guides market report delivers in-depth analysis across all segments, covering key drivers, trends, opportunities, challenges, and restraints. It emphasizes key insights such as disease incidence rates, product launches and approvals, major industry milestones, technological innovations, market share analysis, and profiles of top companies in the industry.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation